Search

everythinglearnresearchcommunity

for

Search:↓

The microbiome may be linked to hair loss and could be a target for new treatments.

Lupus can look like hair loss from alopecia areata but needs different treatment.

A woman with lupus had hair loss and skin issues that were successfully treated with medications.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Some therapies using stem cells and platelet-rich plasma may help treat osteoarthritis, but more research is needed to ensure they are safe and effective.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Alopecia areata treatment varies, with no optimal method established yet.

Exosomes from umbilical cord cells fix hearing loss and damaged ear hair cells in mice.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

Platelet-rich plasma may improve healing and hair growth in cosmetic surgery but results vary.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Melasma treatment is difficult, but combination therapies and personalized plans show promise.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Fractional laser therapy may help regrow hair in alopecia areata.

Lasers and energy-assisted methods show promise for treating hair loss, but more research is needed.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Some chemicals absorbed through the skin can cause serious health problems.

Treatments for melanin disorders exist, but more effective options needed.